Sodium Oxybate in the Treatment of Binge Eating Disorder

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

April 30, 2011

Study Completion Date

April 30, 2011

Conditions
Binge Eating Disorder
Interventions
DRUG

Sodium Oxybate

4.5 g/night - 9 g/night, liquid taken twice per night

Trial Locations (1)

45040

Lindner Center of HOPE, Mason

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Jazz Pharmaceuticals

INDUSTRY

collaborator

University of Cincinnati

OTHER

lead

Lindner Center of HOPE

OTHER